Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule
about
Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen.Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans.
P2860
Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Animal-to-Human Dose Translati ...... x Under the US FDA Animal Rule
@en
Animal-to-Human Dose Translati ...... Under the US FDA Animal Rule.
@nl
type
label
Animal-to-Human Dose Translati ...... x Under the US FDA Animal Rule
@en
Animal-to-Human Dose Translati ...... Under the US FDA Animal Rule.
@nl
prefLabel
Animal-to-Human Dose Translati ...... x Under the US FDA Animal Rule
@en
Animal-to-Human Dose Translati ...... Under the US FDA Animal Rule.
@nl
P2093
P2860
P356
P1476
Animal-to-Human Dose Translati ...... x Under the US FDA Animal Rule
@en
P2093
R Guttendorf
S E Carpenter
P2860
P356
10.1111/CTS.12433
P407
P577
2016-12-07T00:00:00Z